Results 161 to 170 of about 2,478 (201)
Some of the next articles are maybe not open access.

Heterogeneity of Russell's viper venom affects the sensitivity of the dilute Russell's viper venom time to lupus anticoagulants

Blood Coagulation & Fibrinolysis, 2004
A number of studies have shown that commercial dilute Russell's viper venom time (DRVVT) reagents vary in their sensitivity for lupus anticoagulant (LA) detection. The differences in performance are considered to be predominantly due to antibody heterogeneity and a wide variation in phospholipid content, and also the techniques and clot detection ...
Moore, G W, Savidge, G F
openaire   +2 more sources

Notes on the Russell's Viper

1918
(Uploaded by Plazi from the Biodiversity Heritage Library) No abstract provided.
openaire   +1 more source

Russell's viper venom fractions and nephrotoxicity.

The Southeast Asian journal of tropical medicine and public health, 1998
Apparently healthy Wistar rats of body weight 250-300 g were chosen for the experiments. A group of 6 rats were assigned for each fraction. The dose of Russell's viper venom (RVV) fraction used for in vivo experiments was 0.75 microgram/g body weight. Of each batch of 6 rats 3 were sacrificed on the third day and the remaining 3 on the fifth day after ...
T N, Swe   +4 more
openaire   +1 more source

RUSSELL'S VIPER VENOM

The Lancet, 1936
R.G. Macfarlane, Burgess Barnett
openaire   +1 more source

Russell's Viper Bite in Sri Lanka

The American Journal of Tropical Medicine and Hygiene, 1984
Twenty-two patients who had been bitten by a Russell's viper were studied. Neurological manifestations and generalized myalgia were observed, respectively, in 86.4% and 72.7%. Renal failure did not occur in three patients who received antivenin within 5 hours of the bite, and it is suggested that administration of antivenin within the first few hours ...
openaire   +2 more sources

On the Penis of Russell's Viper

1904
(Uploaded by Plazi from the Biodiversity Heritage Library) No abstract provided.
openaire   +1 more source

Inhibition of SARS-CoV-2 replication in the lung with siRNA/VIPER polyplexes

Journal of Controlled Release, 2022
Shubhankar Ambike   +2 more
exaly  

A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite

Nature Communications, 2020
Laura-Oana Albulescu   +2 more
exaly  

Russell's Viper Venom, 1934–64*

British Journal of Haematology, 1967
openaire   +2 more sources

Home - About - Disclaimer - Privacy